1,279
Views
43
CrossRef citations to date
0
Altmetric
Reviews

Lactoferrin: an overview of its main functions, immunomodulatory and antimicrobial role, and clinical significance

, , &

References

  • Abu Hashim, H., O. Foda, and E. Ghayaty. 2017. Lactoferrin or ferrous salts for iron deficiency anemia in pregnancy: A meta-analysis of randomized trials. European Journal of Obstetrics & Gynecology and Reproductive Biology 219:45–52. doi: 10.1016/j.ejogrb.2017.10.003.
  • Actor, J., S.-A. Hwang, and M. Kruzel. 2009. Lactoferrin as a natural immune modulator. Current Pharmaceutical Design 15 (17):1956–73. doi: 10.2174/138161209788453202.
  • Al-Sheikh, H. 2009. Effect of lactoferrin and iron on the growth of human pathogenic Candida species. Pakistan Journal of Biological Sciences: PJBS 12 (1):91–4. doi: 10.3923/pjbs.2009.91.94.
  • Arnold, R. R., J. E. Russell, W. J. Champion, M. Brewer, and J. J. Gauthier. 1982. Bactericidal activity of human lactoferrin: Differentiation from the stasis of iron deprivation. Infection and Immunity 35 (3):792–9. doi: 10.1128/IAI.35.3.792-799.1982.
  • Artym, J., and M. Zimecki. 2013. Milk-derived proteins and peptides in clinical trials. Postepy Higieny i Medycyny Doswiadczalnej 67:800–16. doi: 10.5604/17322693.1061635.
  • Baker, E. N., and H. M. Baker. 2009. A structural framework for understanding the multifunctional character of lactoferrin. Biochimie 91 (1):3–10. doi: 10.1016/j.biochi.2008.05.006.
  • Barboza, M., J. Pinzon, S. Wickramasinghe, J. W. Froehlich, I. Moeller, J. T. Smilowitz, L. R. Ruhaak, J. Huang, B. Lönnerdal, and J. B. German. 2012. Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions. Molecular & Cellular Proteomics 11 (6): M111-015248.
  • Bengoechea, C., O. G. Jones, A. Guerrero, and D. J. McClements. 2011. Formation and characterization of lactoferrin/pectin electrostatic complexes: Impact of composition, pH and thermal treatment. Food Hydrocolloids 25 (5):1227–32. Juldoi: 10.1016/j.foodhyd.2010.11.010.
  • Bennett, R. M., J. Davis, S. Campbell, and S. Portnoff. 1983. Lactoferrin binds to cell membrane DNA. Association of surface DNA with an enriched population of B cells and monocytes. The Journal of Clinical Investigation 71 (3):611–8. doi: 10.1172/jci110807.
  • Bennike, T. B., T. G. Carlsen, T. Ellingsen, O. K. Bonderup, H. Glerup, M. Bøgsted, G. Christiansen, S. Birkelund, A. Stensballe, and V. Andersen. 2015. Neutrophil extracellular traps in ulcerative colitis. Inflammatory Bowel Diseases 21 (9):2052–67.
  • Berlutti, F., C. Morea, A. Battistoni, S. Sarli, P. Cipriani, F. Superti, M. G. Ammendolia, and P. Valenti. 2005. Iron availability influences aggregation, biofilm, adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia. International Journal of Immunopathology and Pharmacology 18 (4):661–70. doi: 10.1177/039463200501800407.
  • Bertuccini, L., M. Costanzo, F. Iosi, A. Tinari, F. Terruzzi, L. Stronati, M. Aloi, S. Cucchiara, and F. Superti. 2014. Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn's disease. Digestive and Liver Disease 46 (6):496–504. doi: 10.1016/j.dld.2014.02.009.
  • Bokkhim, H., N. Bansal, L. GrØndahl, and B. Bhandari. 2013. Physico-chemical properties of different forms of bovine lactoferrin. Food Chemistry 141 (3):3007–13.
  • Bokkhim, H., N. Bansal, L. Grøndahl, and B. Bhandari. 2016. In-vitro digestion of different forms of bovine lactoferrin encapsulated in alginate micro-gel particles. Food Hydrocolloids 52:231–42. doi: 10.1016/j.foodhyd.2015.07.007.
  • Borkowska, A., A. Liberek, G. Łuczak, A. Jankowska, K. Plata-Nazar, M. Korzon, and B. Kamińska. 2015. Fecal lactoferrin, a marker of intestinal inflammation in children with inflammatory bowel disease. Acta Biochimica Polonica 62 (3):541–5. doi: 10.18388/abp.2015_982.
  • Brisson, G., M. Britten, and Y. Pouliot. 2007. Effect of iron saturation on the recovery of lactoferrin in rennet whey coming from heat-treated skim milk. Journal of Dairy Science 90 (6):2655–64. doi: 10.3168/jds.2006-725.
  • Brooks, C. L., E. Arutyunova, and M. J. Lemieux. 2014. The structure of lactoferrin-binding protein B from Neisseria meningitidis suggests roles in iron acquisition and neutralization of host defences. Acta Crystallographica. Section F, Structural Biology Communications 70 (Pt 10):1312–7. doi: 10.1107/S2053230X14019372.
  • Buderus, S., J. H. Boone, and M. J. Lentze. 2015. Fecal lactoferrin: Reliable biomarker for intestinal inflammation in pediatric IBD. Gastroenterology Research and Practice 2015:1–4. doi: 10.1155/2015/578527.
  • Campione, E., T. Cosio, L. Rosa, C. Lanna, S. Girolamo, R. Di, Gaziano, P. Valenti, and L. Bianchi. 2020. Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation. International Journal of Molecular Sciences 21 (14):4903–14. doi: 10.3390/ijms21144903.
  • Chandra Mohan, K. V. P., H. Devaraj, D. Prathiba, Y. Hara, and S. Nagini. 2006. Antiproliferative and apoptosis inducing effect of lactoferrin and black tea polyphenol combination on hamster buccal pouch carcinogenesis. Biochimica et Biophysica Acta 1760 (10):1536–44. https://pubmed.ncbi.nlm.nih.gov/16905260/. doi: 10.1016/j.bbagen.2006.06.009.
  • Chea, C., M. Miyauchi, T. Inubushi, N. F. Ayuningtyas, A. Subarnbhesaj, P. T. Nguyen, M. Shrestha, S. Haing, K. Ohta, and T. Takata. 2018. Molecular mechanism of inhibitory effects of bovine lactoferrin on the growth of oral squamous cell carcinoma. PLoS One 13 (1):e0191683.
  • Chen, J. M., Y. C. Fan, J. W. Lin, Y. Y. Chen, W. L. Hsu, and S. S. Chiou. 2017. Bovine lactoferrin inhibits dengue virus infectivity by interacting with heparan sulfate, low-density lipoprotein receptor, and DC-SIGN. International Journal of Molecular Sciences 18 (9):1957.
  • Chen, K., L. Chai, H. Li, Y. Zhang, H. M. Xie, J. Shang, W. Tian, P. Yang, and A. C. Jiang. 2016. Effect of bovine lactoferrin from iron-fortified formulas on diarrhea and respiratory tract infections of weaned infants in a randomized controlled trial. Nutrition 32 (2):222–7. doi: 10.1016/j.nut.2015.08.010.
  • Chen, P. W., Y. W. Ku, and F. Y. Chu. 2014. Influence of bovine lactoferrin on the growth of selected probiotic bacteria under aerobic conditions. Biometals 27 (5):905–14. doi: 10.1007/s10534-014-9758-z.
  • Chen, P. W., Z. S. Liu, T. C. Kuo, M. C. Hsieh, and Z. W. Li. 2017. Prebiotic effects of bovine lactoferrin on specific probiotic bacteria. Biometals: An International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine 30 (2):237–48.
  • Cheng, J. B., J. Q. Wang, D. P. Bu, G. L. Liu, C. G. Zhang, H. Y. Wei, L. Y. Zhou, and J. Z. Wang. 2008. Factors affecting the lactoferrin concentration in bovine milk. Journal of Dairy Science 91 (3):970–6. doi: 10.3168/jds.2007-0689.
  • Conesa, C., C. Rota, E. Castillo, M. D. Pérez, M. Calvo, and L. Sánchez. 2009. Antibacterial activity of recombinant human lactoferrin from rice: Effect of heat treatment. Bioscience, Biotechnology, and Biochemistry 73 (6):1301–7. doi: 10.1271/bbb.80814.
  • Cornish, J., K. E. Callon, D. Naot, K. P. Palmano, T. Banovic, U. Bava, M. Watson, J.-M. Lin, P. C. Tong, Q. Chen, et al. 2004. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145 (9):4366–74. doi: 10.1210/en.2003-1307.
  • Cornish, J., K. Palmano, K. E. Callon, M. Watson, J. M. Lin, P. Valenti, D. Naot, A. B. Grey, and I. R. Reid. 2006. Lactoferrin and bone; structure-activity relationships. Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire 84 (3):297–302. doi: 10.1139/o06-057.
  • Cox, A. J., A. M. Watts, P. Zhang, L. T. Williams, A. W. Cripps, and N. P. West. 2017. Effects of short-term supplementation with bovine lactoferrin and/or immunoglobulins on body mass and metabolic measures: A randomised controlled trial. International Journal of Food Sciences and Nutrition 68 (2):219–26. doi: 10.1080/09637486.2016.1224230.
  • Cutone, A., L. Rosa, G. Ianiro, M. S. Lepanto, M. C. B. Di Patti, P. Valenti, and G. Musci. 2020. Lactoferrin’s anti-cancer properties: Safety, selectivity, and wide range of action. Biomolecules 10 (3):456. doi: 10.3390/biom10030456.
  • Cutone, A., L. Rosa, M. S. Lepanto, M. J. Scotti, F. Berlutti, M. C. B. di Patti, G. Musci, and P. Valenti. 2017. Lactoferrin efficiently counteracts the inflammation-induced changes of the iron homeostasis system in macrophages. Frontiers Immunology 8:705.
  • Dai, J., W. Z. Liu, Y. P. Zhao, Y. B. Hu, and Z. Z. Ge. 2007. Relationship between fecal lactoferrin and inflammatory bowel disease. Scandinavian Journal of Gastroenterology 42 (12):1440–4. doi: 10.1080/00365520701427094.
  • Damiens, E., I. El Yazidi, J. Mazurier, I. Duthille, G. Spik, and Y. Boilly-Marer. 1999. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. Journal of Cellular Biochemistry 74 (3):486–98. %3C486::AID-JCB16%3E3.0.CO;2-6 .
  • De Kruif, C. G., F. Weinbreck, and R. De Vries. 2004. Complex coacervation of proteins and anionic polysaccharides. Current Opinion in Colloid & Interface Science 9 (5):340–9. doi: 10.1016/j.cocis.2004.09.006.
  • de la Rosa, G., D. Yang, P. Tewary, A. Varadhachary, and J. J. Oppenheim. 2008. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. The Journal of Immunology 180 (10):6868–76. doi: 10.4049/jimmunol.180.10.6868.
  • De Souza Batista, C. M., R. Z. Yang, M. J. Lee, N. M. Glynn, D. Z. Yu, J. Pray, K. Ndubuizu, S. Patil, A. Schwartz, M. Kligman, et al. 2007. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56 (6):1655–61. doi: 10.2337/db06-1506.
  • DI Mario, F., G. Aragona, N. Dal Bo, L. Cavallaro, V. Marcon, P. Olivieri, E. Benedetti, N. Orzes, R. Marin, G. Tafner, et al. 2006. Bovine lactoferrin for Helicobacter pylori eradication: An open, randomized, multicentre study. Alimentary Pharmacology and Therapeutics 23 (8):1235–40. doi: 10.1111/j.1365-2036.2006.02851.x.
  • Donahue, J. E., S. L. Flaherty, C. E. Johanson, J. A. Duncan, G. D. Silverberg, M. C. Miller, R. Tavares, W. Yang, Q. Wu, E. Sabo, et al. 2006. RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease. Acta Neuropathologica 112 (4):405–15.
  • Elass-Rochard, E., D. Legrand, V. Salmon, A. Roseanu, M. Trif, P. S. Tobias, J. Mazurier, and G. Spik. 1998. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infection and Immunity 66 (2):486–91.
  • Embleton, N. D., J. E. Berrington, W. McGuire, C. J. Stewart, and S. P. Cummings. 2013. Lactoferrin: Antimicrobial activity and therapeutic potential. Seminars in Fetal & Neonatal Medicine 18 (3):143–9. doi: 10.1016/j.siny.2013.02.001.
  • Eriksen, E. K., H. Holm, E. Jensen, R. Aaboe, T. G. Devold, M. Jacobsen, and G. E. Vegarud. 2010. Different digestion of caprine whey proteins by human and porcine gastrointestinal enzymes. The British Journal of Nutrition 104 (3):374–81. doi: 10.1017/S0007114510000577.
  • Fernandes, K. E., and D. A. Carter. 2017. The antifungal activity of lactoferrin and its derived peptides: Mechanisms of action and synergy with drugs against fungal pathogens. Frontiers in Microbiology 8:2. doi: 10.3389/fmicb.2017.00002.
  • Fichna, J. 2016. Inflammatory bowel disease treatment. Pharmacological Reports PR 68 (4):787–8. doi: 10.1016/j.pharep.2016.05.008.
  • Fillebeen, C., L. Descamps, M. P. Dehouck, L. Fenart, M. Benaïssa, G. Spik, R. Cecchelli, and A. Pierce. 1999. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. The Journal of Biological Chemistry 274 (11):7011–7. doi: 10.1074/jbc.274.11.7011.
  • Fischer, R., H. Debbabi, A. Blais, M. Dubarry, M. Rautureau, P. N. Boyaka, and D. Tome. 2007. Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues. International Immunopharmacology 7 (10):1387–93. doi: 10.1016/j.intimp.2007.05.019.
  • Fischer, R., H. Debbabi, M. Dubarry, P. Boyaka, and D. Tomé. 2006. Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochemistry and Cell Biology 84:303–11.
  • Furlund, C. B., E. K. Ulleberg, T. G. Devold, R. Flengsrud, M. Jacobsen, C. Sekse, H. Holm, and G. E. Vegarud. 2013. Identification of lactoferrin peptides generated by digestion with human gastrointestinal enzymes. Journal of Dairy Science 96 (1):75–88. doi: 10.3168/jds.2012-5946.
  • Gajda, E., and G. Bugla-Płoskońska. 2014. Lizozym-wystepowanie w przyrodzie, wlas¨ciwos¨ci biologiczne i mozliwosci zastosowań. Postępy Higieny i Medycyny Doświadczalnej 68:1501–15. doi: 10.5604/17322693.1133100.
  • Ganal-Vonarburg, S. C., and C. U. Duerr. 2020. The interaction of intestinal microbiota and innate lymphoid cells in health and disease throughout life. Immunology 159:39–51.
  • García-Montoya, I. A., T. S. Cendón, S. Arévalo-Gallegos, and Q. Rascón-Cruz. 2012. Lactoferrin a multiple bioactive protein: An overview. Biochimica et Biophysica Acta (Bba) - General Subjects 1820 (3):226–36. doi: 10.1016/j.bbagen.2011.06.018.
  • Gaudin, J. C., H. Rabesona, Y. Choiset, G. Yeretssian, J. M. Chobert, V. Sakanyan, M. Drouet, and T. Haertlé. 2008. Assessment of the immunoglobulin E-mediated immune response to milk-specific proteins in allergic patients using microarrays. Clinical and Experimental Allergy 38 (4):686–93. doi: 10.1111/j.1365-2222.2008.02952.x.
  • Gibbons, J. A., J. R. Kanwar, and R. K. Kanwar. 2015. Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer. BMC Cancer 15 (1):1–16.
  • Gisbert, J. P., A. G. McNicholl, and F. Gomollon. 2009. Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease. Inflammatory Bowel Diseases 15:1746–54.
  • Gíslason, J., S. Iyer, T. W. Hutchens, and B. Lönnerdal. 1993. Lactoferrin receptors in piglet small intestine: Lactoferrin binding properties, ontogeny, and regional distribution in the gastrointestinal tract. Journal of Nutritional Biochemistry 4 (9):528–33. doi: 10.1016/0955-2863(93)90089-F.
  • Goldsmith, J. R., and R. B. Sartor. 2014. The role of diet on intestinal microbiota metabolism: Downstream impacts on host immune function and health, and therapeutic implications. Journal of Gastroenterology 49:785–98.
  • González-Chávez, S. A., S. Arévalo-Gallegos, and Q. Rascón-Cruz. 2009. Lactoferrin: Structure, function and applications. International Journal of Antimicrobial Agents 33 (4):301.e1–e8. doi: 10.1016/j.ijantimicag.2008.07.020.
  • Grey, A., T. Banovic, Q. Zhu, M. Watson, K. Callon, K. Palmano, J. Ross, D. Naot, I. R. Reid, and J. Cornish. 2004. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Molecular Endocrinology (Baltimore, Md.) 18 (9):2268–78. doi: 10.1210/me.2003-0456.
  • Griffiths, J., P. Jenkins, M. Vargova, U. Bowler, E. Juszczak, A. King, L. Linsell, D. Murray, C. Partlett, M. Patel, et al. 2019. Enteral lactoferrin supplementation for very preterm infants: A randomised placebo-controlled trial. The Lancet 393 (10170):423–33. doi: 10.1016/S0140-6736(18)32221-9.
  • Groot, F., T. B. H. Geijtenbeek, R. W. Sanders, C. E. Baldwin, M. Sanchez-Hernandez, R. Floris, Y. van Kooyk, E. C. de Jong, and B. Berkhout. 2005. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. Journal of Virology 79 (5):3009–15. doi: 10.1128/JVI.79.5.3009-3015.2005.
  • Haiwen, Z., H. Rui, Z. Bingxi, G. Qingfeng, Z. Jifeng, W. Xuemei, and W. Beibei. 2019. Oral administration of bovine lactoferrin-derived lactoferricin (Lfcin) B could attenuate enterohemorrhagic Escherichia coli O157:H7 induced intestinal disease through improving intestinal barrier function and microbiota. Journal of Agricultural and Food Chemistry 67 (14):3932–45. doi: 10.1021/acs.jafc.9b00861.
  • Hall, C. W., and T. F. Mah. 2017. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiology Reviews 41 (3):276–301. doi: 10.1093/femsre/fux010.
  • Håversen, L. A., L. Baltzer, G. Dolphin, L. A. Hanson, and I. Mattsby-Baltzer. 2003. Anti-inflammatory activities of human lactoferrin in acute dextran sulphate-induced colitis in mice. Scandinavian Journal of Immunology 57 (1):2–10. doi: 10.1046/j.1365-3083.2003.01162.x.
  • Håversen, L., B. G. Ohlsson, M. Hahn-Zoric, L. Å. Hanson, and I. Mattsby-Baltzer. 2002. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB. Cellular Immunology 220 (2):83–95. doi: 10.1016/S0008-8749(03)00006-6.
  • Hayes, T. G., G. F. Falchook, G. R. Varadhachary, D. P. Smith, L. D. Davis, H. M. Dhingra, B. P. Hayes, and A. Varadhachary. 2006. Phase I trial of oral talactoferrin alfa in refractory solid tumors. Investigational New Drugs 24:233–40. doi: 10.1007/s10637-005-3690-6.
  • He, J., and P. Furmanski. 1995. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 373 (6516):721–4. https://www.nature.com/articles/373721a0. doi: 10.1038/373721a0.
  • He, Y. Y., N. T. Lawlor, and D. S. Newburg. 2016. Human milk components modulate toll-like receptor-mediated inflammation. Advances in Nutrition 7 (1):102–11. doi: 10.3945/an.115.010090.
  • He, Y., J. B. Ruganzu, Q. Zheng, X. Wu, H. Jin, X. Peng, B. Ding, C. Lin, S. Ji, Y. Ma, et al. 2020. Silencing of LRP1 exacerbates inflammatory response via TLR4/NF-κB/MAPKs signaling pathways in APP/PS1 transgenic mice. Molecular Neurobiology 57 (9):3727–43. doi: 10.1007/s12035-020-01982-7.
  • Herz, J., and P. Marschang. 2003. Coaxing the LDL receptor family into the fold. Cell. Cell Press 112:289–92.
  • Hoffmann, M., H. Kleine-Weber, S. Schroeder, N. Krüger, T. Herrler, S. Erichsen, T. S. Schiergens, G. Herrler, N.-H. Wu, A. Nitsche, et al. 2020. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor article SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181 (2):271–10. doi: 10.1016/j.cell.2020.02.052.
  • Holtmann, G. J., A. C. Ford, and N. J. Talley. 2016. Pathophysiology of irritable bowel syndrome. The Lancet. Gastroenterology & Hepatology 1 (2):133–46. doi: 10.1016/S2468-1253(16)30023-1.
  • Hunninghake, G. W., K. C. Doerschug, A. B. Nymon, G. A. Schmidt, D. K. Meyerholz, and A. Ashare. 2010. Insulin-like growth factor-1 levels contribute to the development of bacterial translocation in sepsis. American Journal of Respiratory and Critical Care Medicine 182 (4):517–25. doi: 10.1164/rccm.200911-1757OC.
  • Jia, H. P., D. C. Look, L. Shi, M. Hickey, L. Pewe, J. Netland, M. Farzan, C. Wohlford-Lenane, S. Perlman, and P. B. McCray. 2005. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. Journal of Virology 79 (23):14614–21. doi: 10.1128/JVI.79.23.14614-14621.2005.
  • Jiang, R., and B. Lönnerdal. 2017. Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways1. Biochemistry and Cell Biology 95 (1):99–109. doi: 10.1139/bcb-2016-0094.
  • Jimenez, K. M., and C. Gasche. 2019. Management of iron deficiency anaemia in inflammatory bowel disease. Acta Haematologica 142 (1):30–6.
  • Kaufman, D. A., A. Berenz, H. L. Itell, M. Conaway, A. Blackman, J. P. Nataro, and S. R. Permar. 2021. Dose escalation study of bovine lactoferrin in preterm infants: Getting the dose right. Biochemistry and Cell Biology 99 (1):7–13. doi: 10.1139/bcb-2020-0217.
  • Kilic, E., M. V. Novoselova, S. H. Lim, N. A. Pyataev, S. I. Pinyaev, O. A. Kulikov, O. A. Sindeeva, O. A. Mayorova, R. Murney, M. N. Antipina, et al. 2017. Formulation for oral delivery of lactoferrin based on bovine serum albumin and tannic acid multilayer microcapsules. Scientific Reports 7:1–10.
  • Kobayashi, S., R. Sato, O. Inanami, T. Yamamori, O. Yamato, Y. Maede, J. Sato, M. Kuwabara, and Y. Naito. 2005. Reduction of concanavalin A-induced expression of interferon-gamma by bovine lactoferrin in feline peripheral blood mononuclear cells. Veterinary Immunology and Immunopathology 105 (1-2):75–84. doi: 10.1016/j.vetimm.2004.12.016.
  • Kruzel, M. L., A. Bacsi, B. Choudhury, S. Sur, and I. Boldogh. 2006. Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma. Immunology 119 (2):159–66. doi: 10.1111/j.1365-2567.2006.02417.x.
  • Kruzel, M. L., Y. Harari, D. Mailman, J. K. Actor, and M. Zimecki. 2002. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clinical and Experimental Immunology 130 (1):25–31. doi: 10.1046/j.1365-2249.2002.01956.x.
  • Kuwata, H., K. Yamauchi, S. Teraguchi, Y. Ushida, Y. Shimokawa, T. Toida, and H. Hayasawa. 2001. Functional fragments of ingested lactoferrin are resistant to proteolytic degradation in the gastrointestinal tract of adult rats. The Journal of Nutrition 131 (8):2121–7. doi: 10.1093/jn/131.8.2121.
  • Kuwata, H., T.-T. Yip, M. Tomita, and T. W. Hutchens. 1998. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochimica et Biophysica Acta (Bba) - Protein Structure and Molecular Enzymology 1429 (1):129–41. doi: 10.1016/S0167-4838(98)00224-6.
  • Kuwata, H., T. T. Yip, C. L. Yip, M. Tomita, and T. W. Hutchens. 1998. Bactericidal domain of lactoferrin: Detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochemical and Biophysical Research Communications 245 (3):764–73. doi: 10.1006/bbrc.1998.8466.
  • Lambert, L. A., H. Perri, and T. J. Meehan. 2005. Evolution of duplications in the transferrin family of proteins. Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology 140 (1):11–25. doi: 10.1016/j.cbpc.2004.09.012.
  • Lang, J., N. Yang, J. Deng, K. Liu, P. Yang, G. Zhang, and C. Jiang. 2011. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS One 6 (8):e23710. doi: 10.1371/journal.pone.0023710.
  • Langhorst, J., and J. Boone. 2012. Fecal lactoferrin as a noninvasive biomarker in inflammatory bowel diseases. Drugs of Today 48 (2):149–61. doi: 10.1358/dot.2012.48.2.1732555.
  • Latorre, D., P. Puddu, P. Valenti, and S. Gessani. 2010. Reciprocal interactions between lactoferrin and bacterial endotoxins and their role in the regulation of the immune response. Toxins 2 (1):54–68. doi: 10.3390/toxins2010054.
  • Lauterbach, R., E. Kamińska, P. Michalski, and J. P. Lauterbach. 2016. Lactoferrin - A glycoprotein of great therapeutic potentials. Developmental Period Medicine 20 (2):118–25.
  • Lee, T., T. Clavel, K. Smirnov, A. Schmidt, I. Lagkouvardos, A. Walker, M. Lucio, B. Michalke, P. Schmitt-Kopplin, R. Fedorak, et al. 2017. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut 66 (5):863–71. doi: 10.1136/gutjnl-2015-309940.
  • Legrand, D. 2016. Overview of lactoferrin as a natural immune modulator. Journal of Pediatrics 173:S10–S5. doi: 10.1016/j.jpeds.2016.02.071.
  • Legrand, D., E. Elass, M. Carpentier, and J. Mazurier. 2005. Lactoferrin: A modulator of immune and inflammatory responses. Cellular and Molecular Life Sciences: CMLS 62 (22):2549–59. doi: 10.1007/s00018-005-5370-2.
  • Lepanto, M. S., L. Rosa, A. Cutone, M. P. Conte, R. Paesano, and P. Valenti. 2018. Efficacy of lactoferrin oral administration in the treatment of anemia and anemia of inflammation in pregnant and non-pregnant women: An interventional study. Frontiers Immunology 9:2123.
  • Lepanto, M. S., L. Rosa, A. Cutone, M. J. Scotti, A. L. Conte, M. Marazzato, C. Zagaglia, C. Longhi, F. Berlutti, G. Musci, et al. 2019. Bovine lactoferrin pre-treatment induces intracellular killing of AIEC LF82 and reduces bacteria-induced DNA damage in differentiated human enterocytes. International Journal of Molecular Sciences 20 (22):5666. doi: 10.3390/ijms20225666.
  • Li, L., F. Ren, Z. Yun, Y. An, C. Wang, and X. Yan. 2013. Determination of the effects of lactoferrin in a preclinical mouse model of experimental colitis. Molecular Medicine Reports 8 (4):1125–9. doi: 10.3892/mmr.2013.1632.
  • Liao, Y., V. Lopez, T. B. Shafizadeh, C. H. Halsted, and B. Lönnerdal. 2007. Cloning of a pig homologue of the human lactoferrin receptor: Expression and localization during intestinal maturation in piglets. Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology 148 (3):584–90. doi: 10.1016/j.cbpa.2007.08.001.
  • Lin, L., and K. Hu. 2014. LRP-1: Functions, signaling and implications in kidney and other diseases. International Journal of Molecular Sciences 15 (12):22887–901.
  • Lizzi, A. R., V. Carnicelli, M. M. Clarkson, C. Nazzicone, B. Segatore, G. Celenza, M. Aschi, V. Dolo, R. Strom, and G. Amicosante. 2016. Bovine lactoferrin and its tryptic peptides: Antibacterial activity against different species. Applied Biochemistry and Microbiology 52 (4):435–40. doi: 10.1134/S0003683816040116.
  • Lönnerdal, B. 2013. Bioactive proteins in breast milk. Journal of Paediatrics and Child Health 49 (SUPPL. 1):1–7. . doi: 10.1111/jpc.12104.
  • Lönnerdal, B. 2016. Bioactive proteins in human milk: health, nutrition, and implications for infant formulas. The Journal of Pediatrics 173:S4–S9. doi: 10.1016/j.jpeds.2016.02.070.
  • Lönnerdal, B., R. Jiang, and X. Du. 2011. Bovine lactoferrin can be taken up by the human intestinal lactoferrin receptor and exert bioactivities. Journal of Pediatric Gastroenterology and Nutrition 53 (6):1. http://journals.lww.com/00005176-900000000-99269.
  • Machnicki, M., M. Zimecki, and T. Zagulski. 1993. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. International Journal of Experimental Pathology 74 (5):433–9.
  • Mader, J. S., J. Salsman, D. M. Conrad, and D. W. Hoskin. 2005. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Molecular Cancer Therapeutics 4 (4):612–24. doi: 10.1158/1535-7163.MCT-04-0077.
  • Mahalhal, A., J. M. Williams, S. Johnson, N. Ellaby, C. A. Duckworth, M. D. Burkitt, X. Liu, G. L. Hold, B. J. Campbell, and P. D. Mark. 2018. Oral iron exacerbates colitis and influences the intestinal microbiome. PLoS One 13 (10):e0202460.
  • Mancinelli, R., F. Olivero, G. Carpino, D. Overi, L. Rosa, M. S. Lepanto, A. Cutone, A. Franchitto, G. Alpini, P. Onori, et al. 2018. Role of lactoferrin and its receptors on biliary epithelium. Biometals: An International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine 31 (3):369–79.
  • Marek, A., M. Zagierski, A. Liberek, E. Aleksandrowicz, M. Korzon, G. Krzykowski, B. Kamińska, and A. Szlagatys-Sidorkiewicz. 2009. TGF-β1, IL-10 and IL-4 in colostrum of allergic and nonallergic mothers. Acta Biochimica Polonica 56 (3):411–4.
  • Meilinger, M., M. Haumer, K. A. Szakmary, F. Steinböck, B. Scheiber, H. Goldenberg, and M. Huettinger. 1995. Removal of lactoferrin from plasma is mediated by binding to low density lipoprotein receptor-related protein/ α 2 -macroglobulin receptor and transport to endosomes. FEBS Letters 360 (1):70–4. doi: 10.1016/0014-5793(95)00082-K.
  • Mikulic, N., M. A. Uyoga, E. Mwasi, N. U. Stoffel, C. Zeder, S. Karanja, and M. B. Zimmermann. 2020. Iron absorption is greater from apo-lactoferrin and is similar between holo-lactoferrin and ferrous sulfate: stable iron isotope studies in Kenyan infants. The Journal of Nutrition 150:3200–7.
  • Milewska, A., M. Zarebski, P. Nowak, K. Stozek, J. Potempa, and K. Pyrc. 2014. Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells. Journal of Virology 88 (22):13221–30. doi: 10.1128/JVI.02078-14.
  • Miller, J. L. 2013. Iron deficiency anemia: A common and curable disease. Cold Spring Harbor Perspectives Medicine 3 (7):a011866.
  • Mizuki, M., T. Tsukahara, H. Oda, M. Tanaka, K. Yamauchi, F. Abe, and T. Nomiyama. 2020. Effects of lactoferrin on prevention of acute gastrointestinal symptoms in winter: A randomized, double-blinded, placebo-controlled trial for staff of kindergartens and nursery schools in Japan. International Journal of Environmental Research and Public Health 17 (24):9582. doi: 10.3390/ijerph17249582.
  • Mohanraj, R., and S. Sivasankar. 2014. Sweet potato (Ipomoea batatas [L.] Lam)-a valuable medicinal food: A review. Journal of Medicinal Food 17 (7):733–41. doi: 10.1089/jmf.2013.2818.
  • Moore, M. J., T. Dorfman, W. Li, S. K. Wong, Y. Li, J. H. Kuhn, J. Coderre, N. Vasilieva, Z. Han, T. C. Greenough, et al. 2004. Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2. Journal of Virology 78 (19):10628–35.
  • Morgenthau, A., A. Beddek, and A. B. Schryvers. 2014. The negatively charged regions of lactoferrin binding protein B, an adaptation against anti-microbial peptides. PLoS One 9 (1):e86243. doi: 10.1371/journal.pone.0086243.
  • Nakano, M., H. Wakabayashi, H. Sugahara, T. Odamaki, K. Yamauchi, F. Abe, J. Z. Xiao, K. Murakami, K. Ishikawa, and S. Hironaka. 2017. Effects of lactoferrin and lactoperoxidase-containing food on the oral microbiota of older individuals. Microbiology and Immunology 61 (10):416–26. doi: 10.1111/1348-0421.12537.
  • Norrby, K., I. Mattsby-Baltzer, M. Innocenti, and S. Tuneberg. 2001. Orally administered bovine lactoferrin systemically inhibits VEGF165-mediated angiogenesis in the rat. International Journal of Cancer 91 (2):236–40. doi: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1024 > 3.3.CO;2-K.
  • Oh, S. M., C. W. Pyo, Y. Kim, and S. Y. Choi. 2004. Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-kappaB activation cascade . Oncogene 23 (50):8282–91. doi: 10.1038/sj.onc.1208021.
  • Okubo, K., M. Kamiya, Y. Urano, H. Nishi, J. M. Herter, T. Mayadas, D. Hirohama, K. Suzuki, H. Kawakami, M. Tanaka, et al. 2016. Lactoferrin suppresses neutrophil extracellular traps release in inflammation. EBioMedicine 10:204–15. doi: 10.1016/j.ebiom.2016.07.012.
  • Oria, R., L. Sanchez, M. Calvo, M. Ismail, and J. H. Brock. 1993. Effect of heat treatment and other milk proteins on the interaction of lactoferrin with monocytes. The Journal of Dairy Research 60 (3):363–9. https://www.cambridge.org/core/journals/journal-of-dairy-research/article/effect-of-heat-treatment-and-other-milk-proteins-on-the-interaction-of-lactoferrin-with-monocytes/F6CE9B3D32F50FF06EE749EBFFC25727.
  • Ostan, N., A. Morgenthau, R. H. Yu, S. D. Gray-Owen, and A. B. Schryvers. 2017. A comparative, cross-species investigation of the properties and roles of transferrin- and lactoferrin-binding protein B from pathogenic bacteria. Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire 95 (1):5–11. doi: 10.1139/bcb-2016-0055.
  • Ostan, N. K. H., R.-H. Yu, D. Ng, C. C.-L. Lai, A. K. Pogoutse, V. Sarpe, M. Hepburn, J. Sheff, S. Raval, D. C. Schriemer, et al. 2017. Lactoferrin binding protein B - a bi-functional bacterial receptor protein. PLoS Pathogens 13 (3):e1006244. doi: 10.1371/journal.ppat.1006244.
  • Paesano, R., F. Berlutti, M. Pietropaoli, W. Goolsbee, E. Pacifici, and P. Valenti. 2010. Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women. International Journal of Immunopathology and Pharmacology 23 (2):577–87. doi: 10.1177/039463201002300220.
  • Paesano, R., F. Berlutti, M. Pietropaoli, F. Pantanella, E. Pacifici, W. Goolsbee, and P. Valenti. 2010. Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women. Biometals 23 (3):411–7. doi: 10.1007/s10534-010-9335-z.
  • Paesano, R., T. Natalizi, F. Berlutti, and P. Valenti. 2012. Body iron delocalization: The serious drawback in iron disorders in both developing and developed countries. Pathogens and Global Health 106 (4):200–16.
  • Paesano, R., E. Pacifici, S. Benedetti, F. Berlutti, A. Frioni, A. Polimeni, and P. Valenti. 2014. Safety and efficacy of lactoferrin versus ferrous sulphate in curing iron deficiency and iron deficiency anaemia in hereditary thrombophilia pregnant women: An interventional study. Biometals 27 (5):999–1006. doi: 10.1007/s10534-014-9723-x.
  • Paesano, R., M. Pietropaoli, S. Gessani, and P. Valenti. 2009. The influence of lactoferrin, orally administered, on systemic iron homeostasis in pregnant women suffering of iron deficiency and iron deficiency anaemia. Biochimie 91 (1):44–51. doi: 10.1016/j.biochi.2008.06.004.
  • Pan, W. R., P. W. Chen, Y. L. S. Chen, H. C. Hsu, C. C. Lin, and W. J. Chen. 2013. Bovine lactoferricin B induces apoptosis of human gastric cancer cell line AGS by inhibition of autophagy at a late stage. Journal of Dairy Science 96 (12):7511–20. doi: 10.3168/jds.2013-7285.
  • Paulsson, M. A., U. Svensson, A. R. Kishore, and A. S. Naidu. 1993. Thermal behavior of bovine lactoferrin in water and its relation to bacterial interaction and antibacterial activity. Journal of Dairy Science 76 (12):3711–20. doi: 10.3168/jds.S0022-0302(93)77713-9.
  • Paz-Ares, L., V. Hirsh, L. Zhang, F. De Marinis, C.-H. Yang, H. Wakelee, T. Seto, T. Schmelter, T. J. Ong, T. S. K. Mok, et al. 2012. Fortis-M, a randomized, double-blind, placebo-controlled phase 3 study of oral talactoferrin alfa with best supportive care in patients with advanced non-small cell lung cancer following two or more prior regimens- by the Fortis-M Study Group. Annals of Oncology 23:ixe23.
  • Peen, E., A. Johansson, M. Engquist, and T. Skogh. 1998. Hepatic and extrahepatic clearance of circulating human lactoferrin: An experimental study in rat. European Journal of Haematology 61 (3):151–9. doi: 10.1111/j.1600-0609.1998.tb01078.x.
  • Perdijk, O., R. J. J. van Neerven, E. van den Brink, H. F. J. Savelkoul, and S. Brugman. 2018. Bovine lactoferrin modulates dendritic cell differentiation and function. Nutrients 10 (7):848. doi: 10.3390/nu10070848.
  • Peterson, L. W., and D. Artis. 2014. Intestinal epithelial cells: Regulators of barrier function and immune homeostasis. Nature Reviews. Immunology 14 (3):141–53. doi: 10.1038/nri3608.
  • Pfefferkorn, M. D., J. H. Boone, J. T. Nguyen, B. E. Juliar, M. A. Davis, and K. K. Parker. 2010. Utility of fecal lactoferrin in identifying crohn disease activity in children. Journal of Pediatric Gastroenterology & Nutrition 51 (4):425–8. doi: 10.1097/MPG.0b013e3181d67e8f.
  • Pietrantoni, A., A. M. Di Biase, A. Tinari, M. Marchetti, P. Valenti, L. Seganti, and F. Superti. 2003. Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicrobial Agents and Chemotherapy 47 (8):2688–91. doi: 10.1128/AAC.47.8.2688-2691.2003.
  • Pietrantoni, A., C. Fortuna, M. E. Remoli, M. G. Ciufolini, and F. Superti. 2015. Bovine lactoferrin inhibits toscana virus infection by binding to heparan sulphate. Viruses 7 (2):480–95. doi: 10.3390/v7020480.
  • Pires, L. A., R. Hegg, F. R. Freitas, E. R. Tavares, C. P. Almeida, E. C. Baracat, and R. C. Maranhão. 2012. Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer. Brazilian Journal of Medical and Biological Research = Revista Brasileira de Pesquisas Medicas e Biologicas 45 (6):557–64. doi: 10.1590/s0100-879x2012007500068.
  • Prieels, J. P., S. V. Pizzo, L. R. Glasgow, J. C. Paulson, and R. L. Hill. 1978. Hepatic receptor that specifically binds oligosaccharides containing fucosyl alpha1 leads to 3 N-acetylglucosamine linkages. Proceedings of the National Academy of Sciences of the United States of America 75 (5):2215–9. doi: 10.1073/pnas.75.5.2215.
  • Puddu, P., M. G. Carollo, F. Belardelli, P. Valenti, and S. Gessani. 2007. Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages. Journal of Leukocyte Biology 82 (2):347–53. doi: 10.1189/jlb.1106688.
  • Puddu, P., P. Valenti, and S. Gessani. 2009. Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie 91 (1):11–8. doi: 10.1016/j.biochi.2008.05.005.
  • Rao, S. S., Y. Hu, P. L. Xie, J. Cao, Z. X. Wang, J. H. Liu, H. Yin, J. Huang, Y. J. Tan, J. Luo, et al. 2018. Omentin-1 prevents inflammation-induced osteoporosis by downregulating the pro-inflammatory cytokines. Bone Research 6 (1):9. doi: 10.1038/s41413-018-0012-0.
  • Rastogi, N., A. Singh, P. K. Singh, T. K. Tyagi, S. Pandey, K. Shin, P. Kaur, S. Sharma, and T. P. Singh. 2016. Structure of iron saturated C-lobe of bovine lactoferrin at pH 6.8 indicates a weakening of iron coordination. Proteins Struct Proteins 84 (5):591–9. . doi: 10.1002/prot.25004.
  • Rawat, P., S. Kumar, N. Sheokand, C. I. Raje, and M. Raje. 2012. The multifunctional glycolytic protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a novel macrophage lactoferrin receptor. Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire 90 (3):329–38. doi: 10.1139/o11-058.
  • Rezk, M., R. Dawood, M. Abo-Elnasr, A. Al Halaby, and H. Marawan. 2016. Lactoferrin versus ferrous sulphate for the treatment of iron deficiency anemia during pregnancy: A randomized clinical trial. The Journal of Maternal-Fetal & Neonatal Medicine 29 (9):1387–90. doi: 10.3109/14767058.2015.1049149.
  • Rosa, L., A. Cutone, M. S. Lepanto, R. Paesano, and P. Valenti. 2017. Lactoferrin: A natural glycoprotein involved in iron and inflammatory homeostasis. International Journal of Molecular Sciences 18:1985.
  • Roussel-Jazédé, V., I. Jongerius, M. P. Bos, J. Tommassen, and P. van Ulsen. 2010. NalP-mediated proteolytic release of lactoferrin-binding protein B from the meningococcal cell surface. Infection and Immunity 78 (7):3083–9. doi: 10.1128/IAI.01193-09.
  • Rubio, M. G., K. Amo-Mensah, J. M. Gray, V. Q. Nguyen, S. Nakat, D. Grider, K. Love, J. H. Boone, and D. Sorrentino. 2019. Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease. World Journal of Gastrointestinal Pathophysiology 10 (5):54–63. doi: 10.4291/wjgp.v10.i5.54.
  • Sabra, S., and M. M. Agwa. 2020. Lactoferrin, a unique molecule with diverse therapeutical and nanotechnological applications. International Journal of Biological Macromolecules 164:1046–60. doi: 10.1016/j.ijbiomac.2020.07.167.
  • Saidi, H., J. Eslahpazir, J. Eslaphazir, C. Carbonneil, L. Carthagena, M. Requena, N. Nassreddine, and L. Belec. 2006. Differential modulation of human lactoferrin activity against both R5 and X4-HIV-1 adsorption on epithelial cells and dendritic cells by natural antibodies. Journal of Immunology 177 (8):5540–9. doi: 10.4049/jimmunol.177.8.5540.
  • Saito, H., M. Takase, Y. Tamura, S. Shimamura, and M. Tomita. 1994. Physicochemical and antibacterial properties of lactoferrin and its hydrolysate produced by heat treatment at acidic pH. In Advances in experimental medicine and biology, 219–26. New York: Springer LLC.
  • Sano, H., K. Nagai, H. Tsutsumi, and Y. Kuroki. 2003. Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. European Journal of Immunology 33 (10):2894–902. doi: 10.1002/eji.200324218.
  • Sanui, T., M. Takeshita, T. Fukuda, A. Haraguchi, Y. Aida, and F. Nishimura. 2017. Anti-CD14 antibody-treated neutrophils respond to LPS: Possible involvement of CD14 upregulated by anti-CD14 antibody binding. Immunological Investigations 46 (2):190–200. doi: 10.1080/08820139.2016.1238925.
  • Seo, Y. D., X. Jiang, K. M. Sullivan, F. G. Jalikis, K. S. Smythe, A. Abbasi, M. Vignali, J. O. Park, S. K. Daniel, S. M. Pollack, et al. 2019. Mobilization of CD8+ T cells via CXCR4 blockade facilitates PD-1 checkpoint therapy in human pancreatic cancer. Clinical Cancer Research: Research 25 (13):3934–45. doi: 10.1158/1078-0432.CCR-19-0081.
  • Seril, D. N., J. Liao, K. L. K. Ho, A. Warsi, C. S. Yang, and G. Y. Yang. 2002. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Digestive Diseases and Sciences 47 (6):1266–78. doi: 10.1023/A:1015362228659.
  • Serrano, G., I. Kochergina, A. Albors, E. Diaz, G. Hueso, and J. M. Serrano. 2020. Liposomal lactoferrin as potential preventative and cure for COVID-19. International Journal of Health Sciences and Research 8 (1):8–15.
  • Sessa, R., M. Di Pietro, S. Filardo, A. Bressan, P. Mastromarino, A. V. Biasucci, L. Rosa, A. Cutone, F. Berlutti, R. Paesano, et al. 2017. Lactobacilli-lactoferrin interplay in Chlamydia trachomatis infection. Pathogens and Disease 75 (5): ftx054. https://pubmed.ncbi.nlm.nih.gov/28505248/.
  • Shau, H., A. Kim, and S. H. Golub. 1992. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. Journal of Leukocyte Biology 51 (4):343–9. doi: 10.1002/jlb.51.4.343.
  • Shin, K., H. Wakabayashi, K. Yamauchi, T. Yaeshima, and K. Iwatsuki. 2008. Recombinant human intelectin binds bovine lactoferrin and its peptides. Biological & Pharmaceutical Bulletin 31 (8):1605–8. doi: 10.1248/bpb.31.1605.
  • Singh, P. K., M. R. Parsek, E. P. Greenberg, and M. J. Welsh. 2002. A component of innate immunity prevents bacterial biofilm development. Nature 417 (6888):552–5. doi: 10.1038/417552a.
  • Siqueiros-Cendón, T., S. Arévalo-Gallegos, B. F. Iglesias-Figueroa, I. A. García-Montoya, J. Salazar-Martínez, and Q. Rascón-Cruz. 2014. Immunomodulatory effects of lactoferrin. Acta Pharmacologica Sinica 35 (5):557–66. doi: 10.1038/aps.2013.200.
  • Sorimachi, K., K. Akimoto, Y. Hattori, T. Ieiri, and A. Niwa. 1997. Activation of macrophages by lactoferrin: Secretion of TNF-alpha, IL-8 and NO. Biochemistry and Molecular Biology International 43 (1):79–87. doi: 10.1080/15216549700203841.
  • Spik, G., B. Brunet, C. Mazurier‐Dehaine, G. Fontaine, and J. Montreuil. 1982. Characterization and properties of the human and bovine lactotransferrins extracted from the faeces of newborn infants. Acta Paediatrica Scandinavica 71 (6):979–85. doi: 10.1111/j.1651-2227.1982.tb09560.x.
  • Sreedhara, A., R. Flengsrud, V. Prakash, D. Krowarsch, T. Langsrud, P. Kaul, T. G. Devold, and G. E. Vegarud. 2010. A comparison of effects of pH on the thermal stability and conformation of caprine and bovine lactoferrin. International Dairy Journal 20 (7):487–94. doi: 10.1016/j.idairyj.2010.02.003.
  • Steijns, J. M., and A. C. M. Van Hooijdonk. 2000. Occurrence, structure, biochemical properties and technological characteristics of lactoferrin. British Journal of Nutrition 84:11–17.
  • Strunk, T., J. E. Hibbert, D. Doherty, E. Nathan, K. Simmer, S. K. Patole, S. Trend, P. Richmond, D. Burgner, and A. Currie. 2020. Lactoferrin expression is not associated with late-onset sepsis in very preterm infants. Neonatology 117:606–611.
  • Sungnak, W., N. Huang, C. Bécavin, M. Berg, R. Queen, M. Litvinukova, C. Talavera-López, H. Maatz, D. Reichart, F. Sampaziotis, et al. 2020. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nature Medicine 26 (5):681–7. doi: 10.1038/s41591-020-0868-6.
  • Superti, F. 2020. Lactoferrin from bovine milk: A protective companion for life. Nutrients 12:1–26.
  • Superti, F., and F. De Seta. 2020. Warding off recurrent yeast and bacterial vaginal infections: Lactoferrin and lactobacilli. Microorganisms 8:130.
  • Suzuki, Y. A., and B. Lönnerdal. 2002. Characterization of mammalian receptors for lactoferrin. Biochemistry and Cell Biology 80:75–80.
  • Suzuki, Y. A., and B. Lönnerdal. 2004. Baculovirus expression of mouse lactoferrin receptor and tissue distribution in the mouse. Biometals: An International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine 17 (3):301–9.
  • Suzuki, Y. A., V. Lopez, and B. Lönnerdal. 2005. Mammalian lactoferrin receptors: Structure and function. Cellular and Molecular Life Sciences: CMLS 62 (22):2560–75. doi: 10.1007/s00018-005-5371-1.
  • Tarnow-Mordi, W. O., M. E. Abdel-Latif, A. Martin, M. Pammi, K. Robledo, P. Manzoni, D. Osborn, K. Lui, A. Keech, W. Hague, et al. 2020. The effect of lactoferrin supplementation on death or major morbidity in very low birthweight infants (LIFT): A multicentre, double-blind, randomised controlled trial. The Lancet Child & Adolescent Health 4 (6):444–54. doi: 10.1016/S2352-4642(20)30093-6.
  • Tavassoly, O., F. Safavi, and I. Tavassoly. 2020. Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection. Molecular Pharmacology 98 (5):612–9. doi: 10.1124/molpharm.120.000098.
  • Tiwari, V., J. C. Beer, N. V. Sankaranarayanan, M. Swanson-Mungerson, and U. R. Desai. 2020. Discovering small-molecule therapeutics against SARS-CoV-2. Drug Discovery Today 25 (8):1535–44. doi: 10.1016/j.drudis.2020.06.017.
  • Togawa, J. I., H. Nagase, K. Tanaka, M. Inamori, A. Nakajima, N. Ueno, T. Saito, and H. Sekihara. 2002. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Journal of Gastroenterology and Hepatology 17 (12):1291–8. doi: 10.1046/j.1440-1746.2002.02868.x.
  • Togawa, J. I., H. Nagase, K. Tanaka, M. Inamori, T. Umezawa, A. Nakajima, M. Naito, S. Sato, T. Saito, and H. Sekihara. 2002. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. American Journal of Physiology-Gastrointestinal and Liver Physiology 283 (1):46–1.
  • Troost, F. J., W. H. M. Saris, and R. J. M. Brummer. 2002. Orally ingested human lactoferrin is digested and secreted in the upper gastrointestinal tract in vivo in women with ileostomies. The Journal of Nutrition 132 (9):2597–600. doi: 10.1093/jn/132.9.2597.
  • Troost, F. J., J. Steijns, W. H. M. Saris, and R. J. M. Brummer. 2001. Gastric digestion of bovine lactoferrin in vivo in adults. The Journal of Nutrition 131 (8):2101–4. doi: 10.1093/jn/131.8.2101.
  • Tung, Y. T., H. L. Chen, C. C. Yen, P. Y. Lee, H. C. Tsai, M. F. Lin, and C. M. Chen. 2013. Bovine lactoferrin inhibits lung cancer growth through suppression of both inflammation and expression of vascular endothelial growth factor. Journal of Dairy Science 96 (4):2095–106. doi: 10.3168/jds.2012-6153.
  • Van Hooijdonk, A. C. M., K. D. Kussendrager, and J. M. Steijns. 2000. In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. British Journal of Nutrition 84 (S1):127–34. doi: 10.1017/S000711450000235X.
  • Van Veen, H. A., M. E. J. Geerts, P. H. C. Van Berkel, and J. H. Nuijens. 2004. The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis. European Journal of Biochemistry 271 (4):678–84. doi: 10.1111/j.1432-1033.2003.03965.x.
  • Vega-Bautista, A., M. de la Garza, J. C. Carrero, R. Campos-Rodríguez, M. Godínez-Victoria, and M. E. Drago-Serrano. 2019. The impact of lactoferrin on the growth of intestinal inhabitant bacteria. International Journal of Molecular Sciences 20 (19):4707. doi: 10.3390/ijms20194707.
  • Velliyagounder, K., W. Alsaedi, W. Alabdulmohsen, K. Markowitz, and D. H. Fine. 2015. Oral lactoferrin protects against experimental candidiasis in mice. Journal of Applied Microbiology 118 (1):212–21. doi: 10.1111/jam.12666.
  • Venkatesh, M. P., and L. Rong. 2008. Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis. Journal of Medical Microbiology 57 (Pt 9):1113–21. doi: 10.1099/jmm.0.2008/001263-0.
  • Vergara, D., O. López, M. Bustamante, and C. Shene. 2020. An in vitro digestion study of encapsulated lactoferrin in rapeseed phospholipid-based liposomes. Food Chemistry 321:126717. doi: 10.1016/j.foodchem.2020.126717.
  • Vincent, J.-L., J. C. Marshall, R. P. Dellinger, S. G. Simonson, K. Guntupalli, M. M. Levy, M. Singer, and R. Malik. 2015. Talactoferrin in severe sepsis: Results from the phase II/III oral talactoferrin in severe sepsis trial. Critical Care Medicine 43 (9):1832–8. doi: 10.1097/CCM.0000000000001090.
  • Voswinkel, L., T. Vogel, and U. Kulozik. 2016. Impact of the iron saturation of bovine lactoferrin on adsorption to a strong cation exchanger membrane. International Dairy Journal 56:134–40. doi: 10.1016/j.idairyj.2016.01.008.
  • Wakabayashi, H., H. Oda, K. Yamauchi, and F. Abe. 2014. Lactoferrin for prevention of common viral infections. Journal of Infection and Chemotherapy 20 (11):666–71. doi: 10.1016/j.jiac.2014.08.003.
  • Walker, T. R., M. L. Land, A. Kartashov, T. M. Saslowsky, D. M. Lyerly, J. H. Boone, and P. A. Rufo. 2007. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease. Journal of Pediatric Gastroenterology & Nutrition 44 (4):414–22. doi: 10.1097/MPG.0b013e3180308d8e.
  • Wally, J., and S. K. Buchanan. A structural comparison of human serum transferrin and human lactoferrin. In BioMetals, 249–62. Springer; 2007. /pmc/articles/PMC2547852/?report = abstract
  • Wang, B., Y. P. Timilsena, E. Blanch, and B. Adhikari. 2019. Lactoferrin: Structure, function, denaturation and digestion. Critical Reviews in Food Science and Nutrition 59 (4):580–96. doi: 10.1080/10408398.2017.1381583.
  • Ward, P. P., S. Uribe-Luna, and O. M. Conneely. 2002. Lactoferrin and host defense. Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire 80 (1):95–102. doi: 10.1139/o01-214.
  • Weng, T. Y., L. C. Chen, H. W. Shyu, S. H. Chen, J. R. Wang, C. K. Yu, H. Y. Lei, and T. M. Yeh. 2005. Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antiviral Research 67 (1):31–7. doi: 10.1016/j.antiviral.2005.03.005.
  • Wu, J., J. Chen, W. Wu, J. Shi, Y. Zhong, E. A. F. Van Tol, Q. Tang, and W. Cai. 2014. Enteral supplementation of bovine lactoferrin improves gut barrier function in rats after massive bowel resection. British Journal of Nutrition 112 (4):486–92. doi: 10.1017/S000711451400107X.
  • Yao, X., C. Bunt, J. Cornish, S. Y. Quek, and J. Wen. 2013. Oral delivery of lactoferrin: A Review. International Journal of Peptide Research and Therapeutics 19 (2):125–34. doi: 10.1007/s10989-012-9326-8.
  • Zaczyńska, E., M. Kocięba, E. Liwińska, and M. Zimecki. 2014. Bovine lactoferrin enhances proliferation of human peripheral blood lymphocytes and induces cytokine production in whole blood cultures. Advances in Clinical and Experimental Medicine 23 (6):871–6. doi: 10.17219/acem/30168.
  • Żelechowska, P., J. Agier, and E. Brzezińska-Błaszczyk. 2016. Endogenous antimicrobial factors in the treatment of infectious diseases. Central-European Journal of Immunology 41 (4):419–25. doi: 10.5114/ceji.2016.65141.
  • Zhang, G., J. Han, E. J. Welch, R. D. Ye, T. A. Voyno-Yasenetskaya, A. B. Malik, X. Du, and Z. Li. 2009. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. Journal of Immunology 182 (12):7997–8004. doi: 10.4049/jimmunol.0802884.
  • Zhang, Q., C. Chen, M. Swaroop, M. Xu, L. Wang, J. Lee, M. Pradhan, M. Shen, Z. Luo, Y. Xu, et al. 2020. Targeting heparan sulfate proteoglycan-assisted endocytosis as a COVID-19 therapeutic option. bioRxiv.
  • Zhao, X., X. X. Xu, Y. Liu, E. Z. Xi, J. J. An, D. Tabys, and N. Liu. 2019. The in vitro protective role of bovine lactoferrin on intestinal epithelial barrier. Molecules 24 (1):148.
  • Zhou, C., J. Wang, N. Sun, J. Tian, J. Wang, Y. Lv, P. Wang, K. Huang, and H. Che. 2014. Allergenicity of recombinant human lactoferrin to an animal model Brown Norway rats. Food and Agricultural Immunology 25 (1):34–48. doi: 10.1080/09540105.2012.733352.
  • Zielińska, A., M. Sałaga, M. Włodarczyk, and J. Fichna. 2019. Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain. International Journal of Colorectal Disease 34 (2):217–27. doi: 10.1007/s00384-018-3218-0.
  • Zimecki, M., and J. Artym. 2005. Właściwości terapeutyczne białek i peptydów z siary i mleka Therapeutic properties of proteins and peptides from colostrum and milk. Postepy Higieny I Medycyny Doswiadczalnej 59:309–23.
  • Zimecki, M., J. Dawiskiba, B. Zawirska, Z. Krawczyk, and M. Kruzel. 2003. Bovine lactoferrin decreases histopathological changes in the liver and regulates cytokine production by splenocytes of obstructive jaundiced rats. Inflammation Research 52 (7):305–10. doi: 10.1007/s00011-003-1178-4.
  • Zimecki, M., D. Stepniak, A. Szynol, and M. L. Krzuel. 2001. Lactoferrin regulates proliferative response of human peripheral blood mononuclear cells to phytohemagglutinin and mixed lymphocyte reaction. Archivum immunologiae et therapiae experimentalis 49 (2):147–54.
  • Zimecki, M. W. 2001. Lactoferrin regulates the immune responses in post-surgical patients. Archivum immunologiae et therapiae experimentalis 49 (4):325–33.
  • Zimmermann, M. B., C. Chassard, F. Rohner, E. K. N'Goran, C. Nindjin, A. Dostal, J. Utzinger, H. Ghattas, C. Lacroix, and R. F. Hurrell. 2010. The effects of iron fortification on the gut microbiota in African children: A randomized controlled trial in Côte d’Ivoire. The American Journal of Clinical Nutrition 92 (6):1406–15. doi: 10.3945/ajcn.110.004564.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.